Aligos Therapeutics Inc (NASDAQ:ALGS)

1.44
Delayed Data
As of 3:59pm ET
 +0.04 / +2.86%
Today’s Change
1.03
Today|||52-Week Range
17.97
-87.87%
Year-to-Date
No recent news for Aligos Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.43
Day’s range1.41 - 1.45
Volume1,988
Average volume (3 months)282,554
Market cap$64.5M
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)-8.59%
Earnings growth (this year)+25.78%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales108.53
Price/Book0.35

Competitors

No competitors data available.

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$4.4M
Annual profit (last year)-$128.3M
Net profit margin-2,944.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts